Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
The LancetPublished 1 June 2007
Jorma Paavonen, David Jenkins, F. Xavier Bosch, Paulo Naud, Jorge Salmerón, Cosette M. Wheeler
Citations1,300
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The adjuvanted HPV16/18 vaccine showed prophylactic efficacy against cervical intraepithelial neoplasia (CIN) 2+ associated with HPV16 or HPV18 and thus could be used for cervical cancer prevention.
Abstract
The adjuvanted HPV16/18 vaccine showed prophylactic efficacy against CIN2+ associated with HPV16 or HPV18 and thus could be used for cervical cancer prevention.
Keywords
Immunology and MicrobiologyMedicine
Wiley series in probability and statisticsStatistical Methods for Rates and Proportions
18,048 Citations2003Joseph L. Fleiss, Bruce Levin +1 more
The Journal of PathologyHuman papillomavirus is a necessary cause of invasive cervical cancer worldwide
9,038 Citations1999Jan M.M. Walboomers, Marcel V. Jacobs +8 more
The presence of HPV in virtually all cervical cancers implies the highest worldwide attributable fraction so far reported for a specific cause of any major human cancer, and the rationale for HPV testing in addition to, or even instead of, cervical cytology in routine cervical screening.
New England Journal of MedicineEpidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
6,210 Citations2003Núbia Muñóz, F. Xavier Bosch +6 more
In addition to HPV types 16 and 18, types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82Should be considered carcinogenic, or high-risk, types, and types 26, 53, and 66 should be considered probably carcinogenic.
VirologyClassification of papillomaviruses
3,209 Citations2004Ethel-Michele de Villiers, Claude Fauquet +3 more
The higher-order PV taxonomy is described following the general criteria established by the International Committee on the Taxonomy of Viruses (ICTV), reviews the literature of the lower order taxa, lists all known "PV types", and interprets their phylogenetic relationship.
International Journal of CancerHuman papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
1,686 Citations2007Jennifer S. Smith, Lisa Lindsay +5 more
A meta‐analyses of HPV type distribution in invasive cervical cancer (ICC) and high‐grade squamous intraepithelial lesions (HSIL) identified a total of 14,595 and 7,094 cases, respectively, suggesting differences in type‐specific risks for progression.
The LancetSustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
1,637 Citations2006Diane M. Harper, Eduardo L. Franco +8 more
Broad protection against cytohistological outcomes beyond that anticipated for HPV 16/18 and protection against incident infection with HPV 45 and HPV 31 is noted and the vaccine has a good long-term safety profile.
The LancetEfficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
1,634 Citations2004Diane M. Harper, Eduardo L. Franco +14 more
The bivalent HPV vaccine was efficacious in prevention of incident and persistent cervical infections with HPV-16 and HPV-18, and associated cytological abnormalities and lesions.
VaccineThe epidemiology of genital human papillomavirus infection
690 Citations2005Helen Trottier, Eduardo L. Franco
Persistent infection with HR-HPVs is now unequivocally established as a necessary cause of cervical cancer and is likely to be responsible for a substantial proportion of other anogenital neoplasms and upper aero-digestive tract cancers.
New England Journal of MedicineType-Specific Persistence of Human Papillomavirus DNA before the Development of Invasive Cervical Cancer
506 Citations1999K L Wallin, Fredrik Wiklund +6 more
A single positive finding of HPV DNA in a Pap smear confers an increased risk of future invasive cervical cancer that is positive for the same type of virus as identified earlier.
BMJType specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study
423 Citations2002Susanne K. Kjær, Adriaan J. C. van den Brule +8 more
Infection with human papillomavirus precedes the development of low and high grade squamous intraepithelial lesions and for high grade lesions the risk is greatest in women positive for the same type of HPV on repeated testing.
BiometricsApproximately Optimal One-Parameter Boundaries for Group Sequential Trials
341 Citations1987Samuel K. Wang, Anastasios A. Tsiatis
A class of group sequential tests, indexed by a single parameter, that yields approximately optimal results and tables of key values to help in the design ofgroup sequential tests that meet selected specifications.
VaccineEfficacy and other milestones for human papillomavirus vaccine introduction
211 Citations2004Sonia Pagliusi, M. Teresa Aguado
The consultation unanimously agreed that additional clinical bridging studies as well as studies to clarify local epidemiology should be conducted in certain developing countries to determine the potential impact of vaccination and stressed the importance of maintaining existing cervical screening programmes while long-term studies are conducted.
Journal of Clinical MicrobiologyHighly Effective Detection of Human Papillomavirus 16 and 18 DNA by a Testing Algorithm Combining Broad-Spectrum and Type-Specific PCR
165 Citations2006Leen‐Jan van Doorn, Anco Molijn +3 more
Analysis of follow-up samples from more than 1,000 women confirmed that the combination of SPF10-LiPA with additional HPV-16- and HPV-18-TS PCR diminishes the rate of false-negative diagnosis and the novel algorithm offers a highly accurate and effective method for the analysis of HPV infections.
VaccineImmunological analyses of human papillomavirus capsids
151 Citations2001Tzenan Giroglou, Martin Sapp +5 more
Results from epitope blocking experiments suggested a close correlation between primary type-specific capsid antigenic sites and virion neutralization, and support the view that papillomavirus genotypes denote unique viral serotypes, and suggest that a successful vaccine for these viruses will likely require the inclusion of VLPs of each serotype for which protection is desired.
VirologyCharacterization of Events during the Late Stages of HPV16 Infectionin VivoUsing High-Affinity Synthetic Fabs to E4
148 Citations1997John Doorbar, Charmaine Foo +8 more
A large synthetic immunoglobulin library displayed on phage is used to isolate three Fabs which recognize distinct epitopes on the E4 late protein of HPV16, compatible with a role for the HPV16 E4 protein in vegetative DNA replication or in modifying the phenotype of the infected cell to favor virus synthesis or virus release.
Journal of Medical VirologyHuman papillomavirus type specific DNA and RNA persistence—implications for cervical disease progression and monitoring
147 Citations2004Kate Cuschieri, Megan Whitley +1 more
The importance of detecting persistent type specific HPV infection to identify those women more at risk of developing cervical abnormalities, either by repeated DNA genotyping, or potentially by RNA based techniques that may be more predictive of persistent infection if performed at a single time point is highlighted.
Journal of VirologyIdentification of Two Cross-Neutralizing Linear Epitopes within the L1 Major Capsid Protein of Human Papillomaviruses
125 Citations2002Alba-Lucia Combita, Antoine Touzé +3 more
This study confirmed and extended previous studies indicating that most genital HPV genotypes represent separate serotypes, and the results suggest that the classification of serotypes is similar to that of genotypes.
British Journal of CancerProphylactic HPV vaccines: prospects for eliminating ano-genital cancer
70 Citations2007Margaret Stanley
Expert Review of VaccinesPrevention of hepatitis A by Havrix™: a review
42 Citations2005Koen Van Herck, Pierre Van Damme
A recent consensus concluded that hepatitis A vaccines induce lifelong protection, and thus booster vaccinations against hepatitis A are unnecessary in fully immunized, healthy people, and possible future strategies identified.
International Journal of CancerCumulative 5‐year diagnoses of CIN2, CIN3 or cervical cancer after concurrent high‐risk HPV and cytology testing in a primary screening setting
40 Citations2005Heike Hoyer, Cornelia Scheungraber +7 more
The aim of this study was to assess the cumulative 5‐year diagnoses of CIN2, CIN3 or invasive cervical cancer (CIN2+) after concurrent screening by high‐risk HPV test and Pap smear in a primary screening setting.
Archives of VirologyIdentification of type-specific and cross-reactive neutralizing conformational epitopes on the major capsid protein of human papillomavirus type 31
40 Citations2006Maxime Fleury, Antoine Touzé +5 more
Analysis of epitopes on the major capsid protein (L1) of Human papillomavirus (HPV) type 31 using monoclonal antibodies generated against HPV-31 virus-like particles (VLPs) suggested the existence of a cross-neutralizing conformational epitope at the N-terminal part of the FG loop of the major Capsid protein.
Statistics in MedicineStatistical approaches to establishing vaccine safety
27 Citations2002Vladimir Dragalin, Valerii V. Fedorov +1 more
This work evaluates the exact probability of type I error of the likelihood score test, with sample size determined by normal approximation, by enumeration of the binomial outcomes in the rejection region and shows that it exceeds the nominal level.